This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3g9e

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: '''Unreleased structure''' The entry 3g9e is ON HOLD Authors: Ruf, A., Benz, J., Bernardeau, A, Binggeli, A., Blum , D., Boehringer, M., Grether, U., Hilpert, H., Kuhn, B. , Maerki, H.P...)
Next diff →

Revision as of 12:45, 4 March 2009

Unreleased structure

The entry 3g9e is ON HOLD

Authors: Ruf, A., Benz, J., Bernardeau, A, Binggeli, A., Blum , D., Boehringer, M., Grether, U., Hilpert, H., Kuhn, B. , Maerki, H.P., Meyer, M. , Puenterner, K, Raab, S., Schlatter, D., Gsell, B., Stihle, M., Mohr, P.

Description: Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes

Page seeded by OCA on Wed Mar 4 14:45:28 2009

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3g9e"
Personal tools